Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia

TM Weis, BL Marini, DL Bixby, AJ Perissinotti - Critical reviews in oncology …, 2019 - Elsevier
Internal tandem duplications and tyrosine kinase mutations in the fms-like tyrosine kinase 3
(FLT3) receptor can occur in acute myeloid leukemia (AML) and portend a poor prognosis …
被引用次数：46 相关文章

Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia.

TM Weis, BL Marini, DL Bixby… - Critical Reviews in …, 2019 - europepmc.org
Internal tandem duplications and tyrosine kinase mutations in the fms-like tyrosine kinase 3
(FLT3) receptor can occur in acute myeloid leukemia (AML) and portend a poor prognosis …

Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia

TM Weis, BL Marini, DL Bixby… - Critical reviews in …, 2019 - pubmed.ncbi.nlm.nih.gov
Internal tandem duplications and tyrosine kinase mutations in the fms-like tyrosine kinase 3
(FLT3) receptor can occur in acute myeloid leukemia (AML) and portend a poor prognosis …